Skip to main content

UBS Group AG

Position in VERU — Veru Inc.

CIK 1610520 ZURICH, V8

Position in VERU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$255
-$60,174 QoQ
Shares Held
82
-99.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 39% Shared 0% None 61%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Derivatives in VERU

reported options exposure · as of Dec 31, 2022
CallValue
$105,600
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. VERU ranks #531 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VERU

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $255 82
2026-03-31 $60,429 27,344
2025-12-31 $63,200 29,533
2025-09-30 $381,492 100,393
2025-06-30 $959,662 1,654,591
2025-03-31 $963,721 1,966,781
2024-12-31 $291,567 448,565
2024-09-30 $49,608 64,427
2024-06-30 $35,516 42,281
2024-03-31 $1,934 2,763
2023-12-31 $12,479 17,332
2023-09-30 $2,376 3,300
2023-06-30 $31,799 26,722
2023-03-31 $31,020 26,742
2022-12-31 $105,600 20,000
2022-12-31 $265,942 50,368
2022-09-30 $386,910 33,586
2022-06-30 $443,140 39,216
2022-03-31 $185,114 38,326
2021-12-31 $379,704 64,466
2021-09-30 $445,760 52,258
2021-06-30 $733,813 90,931
2021-03-31 $689,995 64,007
2020-12-31 $573,909 66,348
2020-09-30 $165,386 63,125
2020-06-30 $259,578 77,718
2020-03-31 $207,294 63,393